ACW 4.71% 8.1¢ actinogen medical limited

Ann: Actinogen appoints Dr Steven Gourlay as CEO, page-131

  1. 1,575 Posts.
    lightbulb Created with Sketch. 67
    XanaMia is designed to maximise success as below.... so hopefully we get deals from big pharma.... should be within the next two years if it will happen.... same journey as Principia Biopharma I hope......
    dyor

    https://hotcopper.com.au/data/attachments/3111/3111246-f4b58e0c08ae898ef3c87d4ccc347be3.jpg



 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.